Stay updated on MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.

Latest updates to the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label updates from v3.8.0 to v3.8.1; the study record remains unchanged.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record presents details of a completed Phase 1 study evaluating MEDI4736 alone and in combinations for myelodysplastic syndrome, including its treatments, eligibility criteria, locations, and outcome measures.SummaryDifference59%

- Check22 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA sitewide notice announces NIH website changes and says federal agencies are transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check35 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1, while the study record page still displays a 403 error.SummaryDifference0.2%

Stay in the know with updates to MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.